Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula.

@article{Innis2002DocosahexaenoicAA,
  title={Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula.},
  author={Sheila Margaret Innis and David H. Adamkin and Robert T. Hall and Satish C. Kalhan and Cheryl S Lair and Mary O Lim and Dennis C Stevens and Paul F Twist and Deborah A. Diersen-Schade and Cheryl L. Harris and Kimberly L Merkel and James W. Hansen},
  journal={The Journal of pediatrics},
  year={2002},
  volume={140 5},
  pages={547-54}
}
OBJECTIVE To determine if docosahexaenoic acid (DHA) and arachidonic acid (ARA) supplementation influences growth or visual acuity of formula-fed premature infants. STUDY DESIGN Double-blind, multi-center study of 194 premature infants given preterm formula with no DHA or ARA (control), 0.15% energy DHA, or 0.14% DHA + 0.27% ARA from single-cell triglycerides for at least 28 days and then fed term formula (no DHA or ARA) to 57 weeks postmenstrual age (PMA), with 90 breast-fed term infants as… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Similar Papers

Loading similar papers…